LAURA HELSING: Open Payments
NPI 1760723571 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 36 payments from 15 companies in 2025. Trend: 2023 $390 · 2024 $940 · 2025 $1,024
Food & beverage: $924Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $256 |
| Amgen Inc. | 6 | $168 |
| UCB, Inc. | 5 | $138 |
| Janssen Biotech, Inc. | 2 | $130 |
| Lilly USA, LLC | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Organon LLC | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| LEO Pharma Inc. | 1 | $27 |
Products named: Bimzelx, TREMFYA, BOTOX, Otezla, SKYRIZI, DUPIXENT, RINVOQ, Sotyktu.
Industry payments across MA — which companies pay providers there.
